BDH Industries Ltd

BDH

Watchlist

AI Mode

‌

Market Cap

₹ 228 Cr

P/E

23.35

‌

‌
‌

‌

‌
‌

Investment Checklist

How to read checklist?

Performance

MARKET LEADER

Valuation

REASONABLE

Growth

STABLE

Profitability

HIGH MARGIN

Technicals

Bearish

Risk

MODERATE RISK

Investment Checklist

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

Price

PE Ratio

Price

‌

Overview

Detailed Summary

BDH Industries (BDHIL) manufactures a wide range of drug formulations, focusing on antibiotics, anti-inflammatory, and anti-microbial segments. It offers robust Oral Solid Dosages (OSD) technologies.

The company boasts a well-equipped R&D center in Mumbai, dedicated to developing novel drug delivery systems, signaling a commitment to innovation.

BDHIL has entered into a MoU with Nepal's Nepothene Group to assist in setting up a pharmaceutical company, indicating international strategic collaboration.

They expanded into the agro products business as of 2021-22, diversifying their business portfolio.

BDHIL invested in renewable energy by commissioning two wind turbine units, highlighting their drive towards sustainability.

Sector

Pharmaceuticals

Industry

Pharmaceuticals - Indian - Formulations

Market Cap

228 Cr

Volatility

Low Risk

P/E Ratio

23.4

Industry P/E

43.8

PEG Ratio

2.7

P/B Ratio

3.3

52W High

523.75

52W Low

241.00

Sales CAGR

-22.51%

-1.41%

2.26%

10Y

4.00%

Profit CAGR

-6.08%

8.69%

9.31%

10Y

12.45%

ROE

TTM

13.80%

14.73%

14.76%

10Y

14.17%

ROCE

TTM

18.80%

19.77%

19.90%

10Y

19.58%

Technicals

‌

Forecasts

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
ZENOTECH	45.76	285 Cr	99.32	2.96	0.00	3.19	9.08	2.77
SANJIVIN	220.00	264 Cr	35.41	5.89	0.22	16.63	19.07	10.21
SATKARTAR	155.10	246 Cr	25.18	4.77	0.45	23.68	31.80	19.38
BDH	414.75	228 Cr	23.35	3.28	1.14	13.80	18.80	10.96
PHARMAID	49.98	176 Cr	—	3.40	0.00	-31.40	-26.23	-15.87
CORALAB	452.00	163 Cr	9.24	0.77	0.00	8.14	10.97	7.45
PARNAXLAB	127.20	143 Cr	12.93	1.58	0.00	12.26	12.71	5.29

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

AI Mode

Standalone Quarterly Results (in ₹ Crores)

Total Figures

QoQ Changes

Total Figures

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Sales	18	19	21	27	16	16	16	18	19	19
Expenses	16	16	18	23	14	13	13	15	17	16
Operating Profit	1.95	3.17	3.49	3.82	1.96	3.05	3.53	3.06	2.12	3.33
OPM %	10.65	16.38	16.57	14.09	12.05	18.79	21.79	17.17	11.39	17.56
Other Income	0.37	0.41	0.37	0.43	0.38	0.43	0.46	0.57	0.55	0.55
Interest	0.04	0.03	0.02	0.10	0.02	0.04	0.01	0.01	0.01	0.03
Depreciation	0.13	0.13	0.13	0.18	0.22	0.23	0.23	0.23	0.22	0.22
Profit Before Tax	2.16	3.42	3.71	3.97	2.10	3.22	3.75	3.40	2.44	3.63
Tax %	25.00	26.61	25.07	25.19	25.24	25.16	25.07	26.76	25.00	27.82
Net Profit	1.62	2.51	2.78	2.96	1.57	2.41	2.81	2.49	1.83	2.62
EPS in Rs	2.81	4.36	4.82	5.15	2.72	4.18	4.88	4.33	3.17	4.55

Standalone Profit Loss (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	45	41	52	59	57	69	74	86	67	69
Expenses	39	36	45	51	49	60	64	73	55	57
Operating Profit	5.76	5.43	7.00	8.98	8.51	9.08	11	12	12	12
OPM %	12.91	13.22	13.55	15.09	14.82	13.08	14.71	14.48	17.45	17.08
Other Income	1.24	0.82	0.89	0.80	1.30	1.33	0.84	1.58	1.84	2.01
Interest	0.35	0.25	0.52	0.69	0.28	0.23	0.16	0.18	0.07	0.07
Depreciation	0.72	0.75	0.83	0.96	0.79	0.63	0.57	0.57	0.91	0.91
Profit Before Tax	4.98	5.18	6.54	8.12	8.75	9.55	11	13	12	13
Tax %	33.06	27.29	26.19	26.82	27.28	24.40	25.87	25.54	25.62	25.53
Net Profit	3.34	3.76	4.83	5.94	6.36	7.22	8.20	9.87	9.27	9.54
EPS in Rs	5.80	6.54	8.38	10.32	11.04	12.55	14.26	17.14	16.11	16.93
Dividend Payout %	34.48	34.40	32.78	24.22	27.15	28.69	28.07	26.25	27.93	—

Standalone Balance Sheet (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	5.94	5.94	5.94	5.94	5.94	5.94	5.76	5.76	5.76	5.76
Reserves	21	23	25	28	32	37	43	49	56	63
Borrowings	9.46	8.43	7.52	13	9.22	8.51	2.25	4.85	8.69	0.98
Other Liabilities	15	17	18	18	18	19	18	20	23	17
Total Liabilities	52	54	57	66	65	71	69	80	93	87
Fixed Assets	13	23	23	22	21	20	20	19	20	20
CWIP	4.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.35	0.35	0.35
Other Assets	35	31	34	44	44	51	49	61	73	67
Total Assets	52	54	57	66	65	71	69	80	93	87

Standalone Cash Flows (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	4.31	7.21	-0.15	-3.62	11	0.78	3.02	6.29	-1.87	15
Cash from Investing Activity	-4.66	-5.28	0.40	0.59	0.74	1.29	1.38	0.49	-0.31	1.62
Cash from Financing Activity	-0.59	-2.77	-2.54	3.39	-6.37	-2.44	-8.21	0.37	1.36	-10
Net Cash Flow	-0.94	-0.83	-2.29	0.36	5.72	-0.37	-3.81	7.15	-0.82	6.02

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Promoters	49.66%	49.66%	49.66%	49.66%	49.66%	49.66%	49.66%	49.66%	49.66%	49.66%	49.70%	49.70%
FIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.44%	0.28%	0.28%	0.28%	0.28%	0.28%
DIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Public	50.34%	50.34%	50.34%	50.34%	50.34%	50.34%	49.89%	50.06%	50.06%	50.06%	50.03%	50.03%
Total Shareholders	5,911	5,787	5,681	5,165	5,111	5,432	5,246	5,249	5,044	5,002	5,014	4,889

Market Transactions

Date	Party	Category	Type	Avg Price (₹)	Total Value (₹)	Quantity	Percent Traded
Sep 16, 2025	Gopakumar gopalan nair	Insider - Promoter	Disposal	—	—	12,958	0.22
Sep 16, 2025	Nishaant nair	Insider - Promoter Group	Acquisition	—	—	12,958	0.22
Sep 11, 2025	F3 advisors private limited	Bulk	Buy	369.78	1.83 Cr	49,381	0.85
Sep 11, 2025	F3 advisors private limited	Bulk	Sell	362.57	1.45 Cr	40,119	0.69
Nov 22, 2024	Rajesh madhavan unni(huf)	Bulk	Buy	333.26	1.29 Cr	38,825	0.67
Feb 05, 2024	Vramath financial services pr...	Bulk	Buy	241.80	0.89 Cr	36,723	0.63
Jan 01, 2024	S.harsha vijay	Bulk	Buy	244.61	0.73 Cr	30,000	0.52
Jan 01, 2024	Rajesh madhavan unni(huf)	Bulk	Sell	262.67	2.45 Cr	93,242	1.61
Jan 01, 2024	Debashree dey	Bulk	Buy	262.89	0.79 Cr	30,000	0.52
Aug 21, 2023	Rajesh madhavan unni(huf)	Bulk	Buy	211.57	0.62 Cr	29,150	0.50

Projection

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Sorry, no results found!

Documents

Presentations

Concalls

Reports

Presentations

No documents found!

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

AI Mode

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

AI Mode

Standalone Quarterly Results (in ₹ Crores)

Total Figures

QoQ Changes

Total Figures

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Sales	18	19	21	27	16	16	16	18	19	19
Expenses	16	16	18	23	14	13	13	15	17	16
Operating Profit	1.95	3.17	3.49	3.82	1.96	3.05	3.53	3.06	2.12	3.33
OPM %	10.65	16.38	16.57	14.09	12.05	18.79	21.79	17.17	11.39	17.56
Other Income	0.37	0.41	0.37	0.43	0.38	0.43	0.46	0.57	0.55	0.55
Interest	0.04	0.03	0.02	0.10	0.02	0.04	0.01	0.01	0.01	0.03
Depreciation	0.13	0.13	0.13	0.18	0.22	0.23	0.23	0.23	0.22	0.22
Profit Before Tax	2.16	3.42	3.71	3.97	2.10	3.22	3.75	3.40	2.44	3.63
Tax %	25.00	26.61	25.07	25.19	25.24	25.16	25.07	26.76	25.00	27.82
Net Profit	1.62	2.51	2.78	2.96	1.57	2.41	2.81	2.49	1.83	2.62
EPS in Rs	2.81	4.36	4.82	5.15	2.72	4.18	4.88	4.33	3.17	4.55

Standalone Profit Loss (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	45	41	52	59	57	69	74	86	67	69
Expenses	39	36	45	51	49	60	64	73	55	57
Operating Profit	5.76	5.43	7.00	8.98	8.51	9.08	11	12	12	12
OPM %	12.91	13.22	13.55	15.09	14.82	13.08	14.71	14.48	17.45	17.08
Other Income	1.24	0.82	0.89	0.80	1.30	1.33	0.84	1.58	1.84	2.01
Interest	0.35	0.25	0.52	0.69	0.28	0.23	0.16	0.18	0.07	0.07
Depreciation	0.72	0.75	0.83	0.96	0.79	0.63	0.57	0.57	0.91	0.91
Profit Before Tax	4.98	5.18	6.54	8.12	8.75	9.55	11	13	12	13
Tax %	33.06	27.29	26.19	26.82	27.28	24.40	25.87	25.54	25.62	25.53
Net Profit	3.34	3.76	4.83	5.94	6.36	7.22	8.20	9.87	9.27	9.54
EPS in Rs	5.80	6.54	8.38	10.32	11.04	12.55	14.26	17.14	16.11	16.93
Dividend Payout %	34.48	34.40	32.78	24.22	27.15	28.69	28.07	26.25	27.93	—

Standalone Balance Sheet (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	5.94	5.94	5.94	5.94	5.94	5.94	5.76	5.76	5.76	5.76
Reserves	21	23	25	28	32	37	43	49	56	63
Borrowings	9.46	8.43	7.52	13	9.22	8.51	2.25	4.85	8.69	0.98
Other Liabilities	15	17	18	18	18	19	18	20	23	17
Total Liabilities	52	54	57	66	65	71	69	80	93	87
Fixed Assets	13	23	23	22	21	20	20	19	20	20
CWIP	4.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.35	0.35	0.35
Other Assets	35	31	34	44	44	51	49	61	73	67
Total Assets	52	54	57	66	65	71	69	80	93	87

Standalone Cash Flows (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	4.31	7.21	-0.15	-3.62	11	0.78	3.02	6.29	-1.87	15
Cash from Investing Activity	-4.66	-5.28	0.40	0.59	0.74	1.29	1.38	0.49	-0.31	1.62
Cash from Financing Activity	-0.59	-2.77	-2.54	3.39	-6.37	-2.44	-8.21	0.37	1.36	-10
Net Cash Flow	-0.94	-0.83	-2.29	0.36	5.72	-0.37	-3.81	7.15	-0.82	6.02

Oscillators

BearishNeutralBullish

Bullish

Bearish

Neutral

Bullish

Overall

BearishNeutralBullish

Bearish

Neutral

Bullish

Moving Averages

BearishNeutralBullish

Bearish

Neutral

Bullish

Overall

BearishNeutralBullish

Bearish

Neutral

Bullish

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
ZENOTECH	45.76	285 Cr	99.32	2.96	0.00	3.19	9.08	2.77
SANJIVIN	220.00	264 Cr	35.41	5.89	0.22	16.63	19.07	10.21
SATKARTAR	155.10	246 Cr	25.18	4.77	0.45	23.68	31.80	19.38
BDH	414.75	228 Cr	23.35	3.28	1.14	13.80	18.80	10.96
PHARMAID	49.98	176 Cr	—	3.40	0.00	-31.40	-26.23	-15.87
CORALAB	452.00	163 Cr	9.24	0.77	0.00	8.14	10.97	7.45
PARNAXLAB	127.20	143 Cr	12.93	1.58	0.00	12.26	12.71	5.29

Overview

Detailed Summary

BDH Industries (BDHIL) manufactures a wide range of drug formulations, focusing on antibiotics, anti-inflammatory, and anti-microbial segments. It offers robust Oral Solid Dosages (OSD) technologies.

The company boasts a well-equipped R&D center in Mumbai, dedicated to developing novel drug delivery systems, signaling a commitment to innovation.

BDHIL has entered into a MoU with Nepal's Nepothene Group to assist in setting up a pharmaceutical company, indicating international strategic collaboration.

They expanded into the agro products business as of 2021-22, diversifying their business portfolio.

BDHIL invested in renewable energy by commissioning two wind turbine units, highlighting their drive towards sustainability.

Sector

Pharmaceuticals

Industry

Pharmaceuticals - Indian - Formulations

Market Cap

228 Cr

Volatility

Low Risk

P/E Ratio

23.4

Industry P/E

43.8

PEG Ratio

2.7

P/B Ratio

3.3

52W High

523.75

52W Low

241.00

Sales CAGR

-22.51%

-1.41%

2.26%

10Y

4.00%

Profit CAGR

-6.08%

8.69%

9.31%

10Y

12.45%

ROE

TTM

13.80%

14.73%

14.76%

10Y

14.17%

ROCE

TTM

18.80%

19.77%

19.90%

10Y

19.58%